Rite Aid Corporation (USD) Rite Aid Corporation, through its various subsidiaries, manages an extensive network of retail pharmacies across the United States. The company's business activities are structured into two main divisions: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment focuses on dispensing prescription drugs and delivers a wide array of supplementary pharmacy and wellness services. These include administering key immunizations such as those for COVID-19, influenza, and shingles, along with providing assistance to customers managing conditions like hypertension, high cholesterol, and diabetes. It also offers advice on weight loss and quitting smoking, and educates patients on their medications and potential adverse effects. Beyond pharmaceutical care, this segment stocks a broad assortment of consumer goods, including over-the-counter medicines, personal care products, cosmetics, health and beauty aids, seasonal items, household essentials, food, beverages, greeting cards, general merchandise, and pet supplies, complemented by its own private brand line. Furthermore, it operates retail clinics and offers specialized healthcare coaching and disease management solutions to health plans and employers. In contrast, the Pharmacy Services segment provides a complete package of integrated pharmacy benefit management (PBM) offerings. These solutions comprise advanced technology systems, mail-order drug delivery, specialty pharmacy services for complex conditions, efficient network and rebate administration, claims processing, and various pharmacy discount initiatives. This segment is also responsible for managing prescription drug benefits under the federal Medicare Part D program and offering insurance plans to individuals and diverse institutional clients, such as health plans, commercial businesses, labor unions, and governmental entities at state and local levels. As of February 26, 2022, Rite Aid operated 2,450 retail pharmacy outlets spread across 17 states. Established in 1962, the corporation is headquartered in Philadelphia, Pennsylvania.

Rite Aid Corporation (USD) Passive

1200 Intrepid Avenue, Philadelphia, PA, US

Stock Price USD

Price Change

Last Dividend USD

RAD's stock peer is EYEN (Eyenovia, Inc.)

RAD's stock peer is LUMO (Lumos Pharma, Inc.)

RAD's stock peer is RENB (Lunai Bioworks Inc.)

RAD's stock peer is SDCCQ (SmileDirectClub Inc Class A)

RAD's stock peer is SHCR (Sharecare, Inc.)

RAD's stock peer is SHLT (SHL Telemedicine Ltd.)

RAD's stock peer is SNCE (Science 37 Holdings, Inc.)

RAD's stock peer is STSA (Satsuma Pharmaceuticals, Inc.)

RAD's stock peer is TBIO (Telesis Bio, Inc.)

Healthcare Medical - Pharmaceuticals

Rite Aid Corporation, through its various subsidiaries, manages an extensive network of retail pharmacies across the United States. The company's business activities are structured into two main divisions: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment focuses on dispensing prescription drugs and delivers a wide array of supplementary pharmacy and wellness services. These include administering key immunizations such as those for COVID-19, influenza, and shingles, along with providing assistance to customers managing conditions like hypertension, high cholesterol, and diabetes. It also offers advice on weight loss and quitting smoking, and educates patients on their medications and potential adverse effects. Beyond pharmaceutical care, this segment stocks a broad assortment of consumer goods, including over-the-counter medicines, personal care products, cosmetics, health and beauty aids, seasonal items, household essentials, food, beverages, greeting cards, general merchandise, and pet supplies, complemented by its own private brand line. Furthermore, it operates retail clinics and offers specialized healthcare coaching and disease management solutions to health plans and employers. In contrast, the Pharmacy Services segment provides a complete package of integrated pharmacy benefit management (PBM) offerings. These solutions comprise advanced technology systems, mail-order drug delivery, specialty pharmacy services for complex conditions, efficient network and rebate administration, claims processing, and various pharmacy discount initiatives. This segment is also responsible for managing prescription drug benefits under the federal Medicare Part D program and offering insurance plans to individuals and diverse institutional clients, such as health plans, commercial businesses, labor unions, and governmental entities at state and local levels. As of February 26, 2022, Rite Aid operated 2,450 retail pharmacy outlets spread across 17 states. Established in 1962, the corporation is headquartered in Philadelphia, Pennsylvania.

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
1999-10-18	1999-10-25	0.12	4.66 %	Quarterly
1999-07-19	1999-07-26	0.12	2.07 %	Quarterly
1999-04-19	1999-04-26	0.12	1.89 %	Quarterly
1999-01-20	1999-01-25	0.12	0.92 %	Quarterly
1998-10-19	1998-10-26	0.11	1.02 %	Quarterly
1998-07-20	1998-07-27	0.11	1.01 %	Quarterly
1998-04-20	1998-04-27	0.11	1.22 %	Quarterly
1998-01-20	1998-02-02	0.21	1.35 %	Quarterly
1997-10-20	1997-10-27	0.20	1.44 %	Quarterly
1997-07-21	1997-07-28	0.20	1.62 %	Quarterly
1997-04-21	1997-04-28	0.20	1.82 %	Quarterly
1997-01-20	1997-01-27	0.20	2.01 %	Quarterly
1996-11-12		0.01	1.40 %	Monthly
1996-10-21	1996-10-28	0.18	2.14 %	Quarterly
1996-07-22	1996-07-29	0.18	2.46 %	Quarterly
1996-04-22	1996-04-29	0.18	2.29 %	Quarterly
1996-01-22	1996-01-29	0.18	2.22 %	Quarterly
1995-10-23	1995-10-30	0.17	2.41 %	Quarterly
1995-07-24	1995-07-31	0.17	2.35 %	Quarterly
1995-04-24	1995-05-01	0.17	2.80 %	Quarterly
1995-01-16	1995-01-23	0.17	2.60 %	Quarterly
1994-10-17	1994-10-24	0.15	2.68 %	Quarterly
1994-07-18	1994-07-25	0.15	3.00 %	Quarterly
1994-04-18	1994-04-25	0.15	3.16 %	Quarterly
1994-01-17	1994-01-24	0.15	3.12 %	Quarterly
1993-10-18	1993-10-25	0.15	3.81 %	Quarterly
1993-07-19	1993-07-26	0.15	3.20 %	Quarterly
1993-04-19	1993-04-26	0.15	3.04 %	Quarterly
1993-01-18	1993-01-25	0.15	2.74 %	Quarterly
1992-10-19	1992-10-26	0.14	2.47 %	Quarterly
1992-07-20	1992-07-27	0.14	2.64 %	Quarterly
1992-04-20	1992-04-27	0.14	2.46 %	Quarterly
1992-01-20	1992-01-27	0.14	2.33 %	Quarterly
1991-10-21	1991-10-28	0.12	2.29 %	Quarterly
1991-07-22	1991-07-29	0.12	2.32 %	Quarterly
1991-04-22	1991-04-29	0.25	2.03 %	Quarterly
1991-01-21	1991-01-28	0.25	2.58 %	Quarterly
1990-10-22	1990-10-29	0.23	2.87 %	Quarterly
1990-07-23	1990-07-30	0.23	2.31 %	Quarterly
1990-04-23	1990-04-30	0.23	2.57 %	Quarterly
1990-01-22	1990-01-29	0.23	2.66 %	Quarterly
1989-10-23	1989-10-30	0.21	2.15 %	Quarterly
1989-07-24	1989-07-31	0.21	2.12 %	Quarterly
1989-04-24	1989-05-01	0.21	2.18 %	Quarterly
1989-01-13	1989-01-23	0.21	2.35 %	Quarterly
1988-10-17	1988-10-24	0.19	1.94 %	Quarterly
1988-07-18	1988-07-25	0.19	2.02 %	Quarterly
1988-04-18	1988-04-25	0.19	1.73 %	Quarterly
1988-01-18	1988-01-25	0.19	2.06 %	Quarterly
1987-10-19	1987-10-26	0.17	1.71 %	Quarterly
1987-07-20	1987-07-27	0.17	1.54 %	Quarterly
1987-04-20	1987-04-27	0.17	1.82 %	Quarterly
1987-01-16	1987-01-26	0.17	1.83 %	Quarterly
		0.15	2.07 %	Quarterly
		0.15	1.71 %	Quarterly
		0.15	1.86 %	Quarterly
		0.15	2.09 %	Quarterly
		0.12	2.29 %	Quarterly
		0.12	1.43 %	Quarterly
		0.12	0.87 %	Quarterly
		0.12	0.51 %	Quarterly

Recent News

AITX's RAD Announces Additional Healthcare and Construction Orders as Customers Expand Deployments

Recent Deployments Drive Follow on Expansion Activity Across Multiple Sites and Support Continued Growth in Recurring Revenue Opportunities Detroit, Michigan--(Newsfile Corp. - June 18, 2026) - Artificial Intelligence Technology Solutions, Inc. (OTCID: AITX) (the "Company"), a developer and operator of AI-driven security and productivity solutions for enterprise clients, along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), today announced additional orders from recently announced healthcare and construction customers. The orders include three RIO™ 180 solar powered security trailers for deployment at healthcare facilities in California and two RIO Mini units, each integrated with the Company's SARA™ (Speaking Autonomous Responsive Agent) agentic AI platform, for a large construction project on the East Coast.

2026-06-18 08:40:00

RAD Amplify Appoints John King as Senior Vice President, Head of Marketing

NEW YORK--(BUSINESS WIRE)-- #AIMarketing--RAD Amplify, a RAD Intel portfolio company built at the intersection of audience intelligence and creator marketing, today announced the appointment of John King as Senior Vice President, Head of Marketing. King will lead brand and content strategy, demand generation, marketing communications, and sales enablement across enterprise brands, agencies, and strategic partners.The appointment comes as brands continue to shift media investment decisively toward creator marke.

2026-06-17 06:00:00

Recludix Pharma to Present Preclinical Asthma and Dermatitis Data for Oral STAT6 Inhibitor REX-8756 at the European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic Dermatitis (RAD) Congresses

SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced preclinical data for REX-8756, an oral, potent and selective STAT6 inhibitor, is being presented at two upcoming scientific congresses. At the European Association of Allergy and Clinical Immunology (EAACI) Congress taking place June 12-15, 2026, in Istanbul, Turkey, a poster will highlight data with REX-8756 from in vivo models of allergic asthma and dermatitis. At the Revolutionizing Atopic Dermatitis (RAD) Congress taking place June 17-19, 2026, in Nashville, TN, data from a preclinical model of atopic dermatitis and an in vivo pharmacokinetic and pharmacodynamic (PK/PD) model will be featured in a poster presentation.

2026-06-12 08:00:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions